References
Ahn KS, Sethi G, Sung B, Goel A, Ralhan R, & Aggarwal BB (2008). Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer research 68: 4406-4415.
Aoki Y, Feldman GM, & Tosato G (2003). Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101:1535-1542.
Arora L, Kumar AP, Arfuso F, Chng WJ, & Sethi G (2018). The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies. Cancers 10.
Artal Cortes A, Calera Urquizu L, & Hernando Cubero J (2015). Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art. Translational lung cancer research 4:191-197.
Ashrafizadeh M, Ahmadi Z, Kotla NG, Afshar EG, Samarghandian S, Mandegary A, et al. (2019). Nanoparticles Targeting STATs in Cancer Therapy. Cells 8.
Baek SH, Ko JH, Lee H, Jung J, Kong M, Lee JW, et al. (2016a). Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Phytomedicine : international journal of phytotherapy and phytopharmacology 23:566-577.
Baek SH, Lee JH, Kim C, Ko JH, Ryu SH, Lee SG, et al. (2017). Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase. Molecules 22.
Baek SH, Lee JH, Ko JH, Lee H, Nam D, Lee SG, et al. (2016b). Ginkgetin Blocks Constitutive STAT3 Activation and Induces Apoptosis through Induction of SHP-1 and PTEN Tyrosine Phosphatases. Phytotherapy research : PTR 30: 567-576.
Banerjee K, & Resat H (2016). Constitutive activation of STAT3 in breast cancer cells: A review. International journal of cancer 138: 2570-2578.
Bharti AC, Donato N, & Aggarwal BB (2003). Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. Journal of immunology 171: 3863-3871.
Bowman T, Garcia R, Turkson J, & Jove R (2000). STATs in oncogenesis. Oncogene 19: 2474-2488.
Chai EZ, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, et al. (2016). Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacology & therapeutics 162: 86-97.
Dai X, Ahn KS, Wang LZ, Kim C, Deivasigamni A, Arfuso F, et al. (2016). Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Molecular cancer therapeutics 15: 2966-2976.
Dai X, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, et al. (2015). Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy. Experimental biology and medicine 240: 760-773.
Elson A, & Leder P (1995). Identification of a cytoplasmic, phorbol ester-inducible isoform of protein tyrosine phosphatase epsilon. Proceedings of the National Academy of Sciences of the United States of America 92:12235-12239.
Fathi N, Rashidi G, Khodadadi A, Shahi S, & Sharifi S (2018). STAT3 and apoptosis challenges in cancer. International journal of biological macromolecules 117:993-1001.
Huang P, Zhang L, Chai C, Qian XC, Li W, Li JS, et al. (2014). Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract. Journal of pharmaceutical and biomedical analysis 100: 138-144.
Huang Q, Li L, Li L, Chen H, Dang Y, Zhang J, et al. (2016). MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer. Oncotarget 7: 44013-44022.
Huang WC, Chen YL, Liu HC, Wu SJ, & Liou CJ (2018). Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 26:1178-1184.
Hwang ST, Kim C, Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, et al. (2019). Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine : international journal of phytotherapy and phytopharmacology 59: 152907.
Jung YY, Lee JH, Nam D, Narula AS, Namjoshi OA, Blough BE, et al. (2018). Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade. Frontiers in pharmacology 9: 531.
Jung YY, Shanmugam MK, Narula AS, Kim C, Lee JH, Namjoshi OA, et al. (2019). Oxymatrine Attenuates Tumor Growth and Deactivates STAT5 Signaling in a Lung Cancer Xenograft Model. Cancers 11: 49.
Kim C, Cho SK, Kapoor S, Kumar A, Vali S, Abbasi T, et al. (2014). beta-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase. Molecular carcinogenesis 53: 793-806.
Kim C, Lee SG, Yang WM, Arfuso F, Um JY, Kumar AP, et al. (2018). Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. Cancer letters 431: 123-141.
Kim M, Morales LD, Jang IS, Cho YY, & Kim DJ (2018). Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling. International journal of molecular sciences 19.
Ko JH, Nam D, Um JY, Jung SH, Sethi G, & Ahn KS (2018). Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition. Molecules 23: 1601.
Lee JH, Chiang SY, Nam D, Chung WS, Lee J, Na YS, et al. (2014). Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer letters 345: 140-148.
Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, & Ahn KS (2019). Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Pharmacological research 150: 104504.
Lee JH, Kim C, Baek SH, Ko JH, Lee SG, Yang WM, et al. (2017). Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer. Oncotarget 8: 17700-17711.
Lee JH, Kim C, Kim SH, Sethi G, & Ahn KS (2015). Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway. Cancer letters 360: 280-293.
Lee JH, Kim C, Lee J, Um JY, Sethi G, & Ahn KS (2019). Arctiin is a pharmacological inhibitor of STAT3 phosphorylation at tyrosine 705 residue and potentiates bortezomib-induced apoptotic and anti-angiogenic effects in human multiple myeloma cells. Phytomedicine : international journal of phytotherapy and phytopharmacology 55: 282-292.
Lee JH, Kim C, Lee SG, Sethi G, & Ahn KS (2018a). Ophiopogonin D, a Steroidal Glycoside Abrogates STAT3 Signaling Cascade and Exhibits Anti-Cancer Activity by Causing GSH/GSSG Imbalance in Lung Carcinoma. Cancers 10: 427.
Lee JH, Kim C, Lee SG, Sethi G, & Ahn KS (2018b). Ophiopogonin D, a Steroidal Glycoside Abrogates STAT3 Signaling Cascade and Exhibits Anti-Cancer Activity by Causing GSH/GSSG Imbalance in Lung Carcinoma. Cancers 10.
Lee JH, Kim C, Lee SG, Yang WM, Um JY, Sethi G, et al. (2018). Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells. Phytomedicine : international journal of phytotherapy and phytopharmacology 40:165-175.
Lee JH, Kim C, Sethi G, & Ahn KS (2015). Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel. Oncotarget 6: 6386-6405.
Lee JH, Mohan CD, Basappa S, Rangappa S, Chinnathambi A, Alahmadi TA, et al. (2019a). The IkappaB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells. Biomolecules 9: 875.
Lee JH, Mohan CD, Basappa S, Rangappa S, Chinnathambi A, Alahmadi TA, et al. (2019b). The IkappaB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells. Biomolecules 9.
Lee JH, Rangappa S, Mohan CD, Basappa, Sethi G, Lin ZX, et al. (2019c). Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma. Biomolecules 9: 550.
Li F, Shanmugam MK, Chen L, Chatterjee S, Basha J, Kumar AP, et al. (2013). Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer prevention research 6: 843-854.
Liou CJ, Lai XY, Chen YL, Wang CL, Wei CH, & Huang WC (2015). Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2015: 298635.
Liu G, Kuang S, Wu S, Jin W, & Sun C (2016). A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo. Scientific reports 6: 26722.
Loh CY, Arya A, Naema AF, Wong WF, Sethi G, & Looi CY (2019). Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication. Frontiers in oncology 9: 48.
Mason GA (1949). Cancer of the lung; review of 1,000 cases. Lancet 2: 587-591.
Mohan CD, Rangappa S, Preetham HD, Chandra Nayaka S, Gupta VK, Basappa S, et al. (2020). Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature. Seminars in cancer biology.
Nakamura K, Mizuno Y, & Kikuchi K (1996). Molecular cloning of a novel cytoplasmic protein tyrosine phosphatase PTP epsilon. Biochemical and biophysical research communications 218: 726-732.
Reck M, Heigener DF, Mok T, Soria JC, & Rabe KF (2013). Management of non-small-cell lung cancer: recent developments. Lancet 382: 709-719.
Schindler C, Levy DE, & Decker T (2007). JAK-STAT signaling: from interferons to cytokines. The Journal of biological chemistry 282: 20059-20063.
Shanmugam MK, Rajendran P, Li F, Kim C, Sikka S, Siveen KS, et al. (2015). Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model. Molecular carcinogenesis 54: 971-985.
Shanmugam MK, Warrier S, Kumar AP, Sethi G, & Arfuso F (2017). Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer. Current vascular pharmacology 15: 503-519.
Siegel RL, Miller KD, & Jemal A (2015). Cancer statistics, 2015. CA: a cancer journal for clinicians 65: 5-29.
Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, et al. (2014). Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget 5: 1897-1911.
Tanuma N, Nakamura K, & Kikuchi K (1999). Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. European journal of biochemistry 259: 46-54.
Tanuma N, Nakamura K, Shima H, & Kikuchi K (2000). Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. The Journal of biological chemistry 275: 28216-28221.
Tanuma N, Shima H, Nakamura K, & Kikuchi K (2001). Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling. Blood 98: 3030-3034.
Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov AG, et al. (2018). Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention. Pharmacological research 128: 366-375.
Wang L, Syn NL, Subhash VV, Any Y, Thuya WL, Cheow ESH, et al. (2018). Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling. Cancer letters 417: 152-160.
Wang SW, & Sun YM (2014). The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review). International journal of oncology 44: 1032-1040.
Wong ALA, Hirpara JL, Pervaiz S, Eu JQ, Sethi G, & Goh BC (2017). Do STAT3 inhibitors have potential in the future for cancer therapy? Expert opinion on investigational drugs 26: 883-887.
Xu L, Hu Z, Shen J, & McQuillan PM (2015). Effects of Ginkgo biloba extract on cerebral oxygen and glucose metabolism in elderly patients with pre-existing cerebral ischemia. Complementary therapies in medicine 23: 220-225.
Yang MH, Jung SH, Chinnathambi A, Alahmadi TA, Alharbi SA, Sethi G, et al. (2019). Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma. Biomolecules 10.
Yang MH, Lee JH, Ko JH, Jung SH, Sethi G, & Ahn KS (2019). Brassinin Represses Invasive Potential of Lung Carcinoma Cells through Deactivation of PI3K/Akt/mTOR Signaling Cascade. Molecules 24: 1584.
Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, et al. (2005). Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128: 452-462.
Yeh KY, Shou SS, Lin YX, Chen CC, Chiang CY, & Yeh CY (2015). Effect of Ginkgo biloba extract on lipopolysaccharide-induced anhedonic depressive-like behavior in male rats. Phytotherapy research : PTR 29: 260-266.
Yu H, Pardoll D, & Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nature reviews Cancer 9: 798-809.
Zhang N, Zeng Y, Du W, Zhu J, Shen D, Liu Z, et al. (2016). The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. International journal of oncology 49: 1360-1368.
Zhang R, Han D, Li Z, Shen C, Zhang Y, Li J, et al. (2018). Ginkgolide C Alleviates Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Inhibition of CD40-NF-kappaB Pathway. Frontiers in pharmacology 9: 109.
Zhou B, Shetye G, Yu Y, Santarsiero BD, Klein LL, Abad-Zapatero C, et al. (2020). Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502. Journal of natural products 83: 657-667.
Zhu H, Chang LL, Yan FJ, Hu Y, Zeng CM, Zhou TY, et al. (2018). AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer. Theranostics 8:676-692.